Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy - - Pharmaphorum

Retrieved on: 2022-08-16 16:20:59

Tags for this article:

Click the tags to see associated articles and topics

Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy - - Pharmaphorum. View article details on hiswai:

Excerpt

FDA is scheduled to deliver a verdict on Roche's Polivy in previously untreated diffuse large B-cell lymphoma by 2 April; pharma company says it ...

Article found on: pharmaphorum.com